These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1588733)

  • 1. [Biotechnology for rheumatology researches].
    Yamamoto K
    Nihon Rinsho; 1992 Mar; 50(3):468-72. PubMed ID: 1588733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnology: a selective survey.
    Goldsby RA
    Avian Dis; 1986; 30(1):3-11. PubMed ID: 3460566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of chimeric antibodies: cloning of immunoglobulin genes including their promoter regions by PCR.
    Mocikat R; Kütemeier G; Harloff C
    Biotechniques; 1992 Mar; 12(3):355-6. PubMed ID: 1571141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of polymerase chain reaction (PCR) in the development of a recombinant organism.
    Helder JC; Utter SL
    Dev Biol Stand; 1994; 83():87-92. PubMed ID: 7883103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic applications of genetic engineering].
    Descamps JL
    Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnology: an introduction to recombinant DNA technology and product availability.
    Evens RP; Witcher M
    Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of phage libraries for the in vitro production of recombinant monoclonal antibodies of predetermined specificity].
    Flego M; Ascione A; Pini A; Mennella V; Dupuis ML; Benagiano G; Cianfriglia M
    Ann Ist Super Sanita; 2002; 38(4):401-10. PubMed ID: 12760337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene technology].
    Blum HE; Moradpour D
    Dtsch Med Wochenschr; 1999 Nov; 124(46):1393-4. PubMed ID: 10599250
    [No Abstract]   [Full Text] [Related]  

  • 9. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ['New look' biotechnology].
    de Voogd van der Straaten WA
    Tijdschr Diergeneeskd; 1987 Jan; 112(1):3-8. PubMed ID: 3469783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant antibodies in serologic diagnosis].
    Wölpl A; Cardoso M; Siemoneit K; Koerner K; Kubanek B
    Beitr Infusionsther; 1993; 31():147-51. PubMed ID: 7693244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct cDNA cloning of the rearranged immunoglobulin variable region.
    Chiang YL; Sheng-Dong R; Brow MA; Larrick JW
    Biotechniques; 1989 Apr; 7(4):360-6. PubMed ID: 2629848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnology in transfusion medicine.
    Sonneborn HH
    Beitr Infusionsther; 1992; 30():1-5. PubMed ID: 1284682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant antibodies.
    Larrick JW; Fry KE
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):172-89. PubMed ID: 1751781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What can experimental research offer to rheumatology today--the viewpoint of molecular biology? Contribution of molecular biology to pathogenesis research in rheumatology using the example of rheumatoid arthritis].
    Kunisch E; Pohlers D; Dunger S; Huber R; Kreusch A; Wiederanders B; Kinne RW
    Z Rheumatol; 2002; 61 Suppl 2():II/1-5. PubMed ID: 12491114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody engineering: an overview.
    O'Kennedy R; Roben P
    Essays Biochem; 1991; 26():59-75. PubMed ID: 1778186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Mycobacterium tuberculosis genoma and production of a recombinant protein containing specific B and T cell antigenic determinants--new approaches to second generation antituberculosis vaccines.
    Colizzi V; Vismara D; D'Urso C; Mezzopreti MF; Lombardi G; Piccolella E; Damiani G; Marelli P; Campa M
    Z Erkr Atmungsorgane; 1989; 172(1):40-52. PubMed ID: 2467445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress in gene engineered antibodies].
    Xiong SD; Wen BG; Li GW
    Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):23-6. PubMed ID: 12545772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prospective of the biotechnology industry on changing technology in pathology.
    Schoepke HG
    Arch Pathol Lab Med; 1987 Jul; 111(7):596-600. PubMed ID: 3475045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of new cloning techniques on the diagnosis and treatment of infectious diseases.
    Engleberg NC; Eisenstein BI
    N Engl J Med; 1984 Oct; 311(14):892-901. PubMed ID: 6433200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.